TAVR-PACER. A retrospective, multicentric, multimodal study to establish a comprehensive risk-assessment-score for pacemaker indications in patients undergoing TAVR.

TAVR-PACER. A retrospective, multicentric, multimodal study to establish a comprehensive risk-assessment-score for pacemaker indications in patients undergoing TAVR. - TAVR PACER

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00024852

Enrollment

1000

Registered

2021-04-22

Start date

2019-01-03

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I35.0 I44.2 I44.1 I49.9 R00.1

Interventions

Group 1: Pre-TAVR: - CT (ECG- and Non-ECG-triggered) - TTE - ECG - Clinical Data During TAVR: - Intraoperative Data Post-TAVR: - ECG - Pacemaker Query (if applicable)

Eligibility

Sex/Gender

All

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Received a TAVR

Exclusion criteria

Exclusion criteria: Surgical aortic valve replacement

Design outcomes

Primary

Measure	Time frame
Identification of factors that influence the peri-/post-procedural pacemaker risk in TAVR-patients.	—

Secondary

Measure	Time frame
Establishment of a risk-assessment score.	—

Countries

Germany

Contacts

Public ContactBenjamin Juri

Medizinische Klinik für Kardiologie - Charité - Universitätsmedizin Berlin - Campus Benjamin Franklin

benjamin.juri@charite.de004930450613635

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026